WO1999065861A1 - Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien - Google Patents
Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien Download PDFInfo
- Publication number
- WO1999065861A1 WO1999065861A1 PCT/EP1999/004253 EP9904253W WO9965861A1 WO 1999065861 A1 WO1999065861 A1 WO 1999065861A1 EP 9904253 W EP9904253 W EP 9904253W WO 9965861 A1 WO9965861 A1 WO 9965861A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- general formula
- atoms
- carbon atoms
- iii
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/023—Preparation; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
Definitions
- the present invention relates to a method for disubstituting carboxamides with a Grignard reagent in the presence of organotitanium compounds.
- the invention therefore relates to a process for the preparation of compounds of the general formula (I)
- 5 can be and together form a cyclic ring with 3 to 8 carbon atoms, which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group -S-, -O- and -NR 6 -,
- R 8 and R 9 have the given meanings or R 8 and R 9 are connected to one another and together form a cyclic ring with 3 to 8 C atoms, which optionally in addition to a nitrogen atom
- R 4 and R 5 have at most one hydrogen atom in the ⁇ position.
- R 6 , R 7 , R 8 and R 9 independently of one another A or Ar
- A is a straight-chain or branched alkyl radical with 1 to 10 C-
- Atoms straight-chain or branched alkenyl radical with 2 to 10 C atoms, or straight-chain or branched 25 alkynyl radical with 2-10 C atoms or substituted or unsubstituted cycloalkyl radical with 3-8 C atoms, mono- or polyunsaturated cycloalkyl radical with 3-8 Carbon atoms and
- Ar is a substituted or unsubstituted aryl radical with 6-20 C
- Atoms mean, characterized in that a compound of the general formula (II)
- R has the meaning given for formula (I), and X Cl, Br, I and
- n is an integer from 1 to 3
- Organotitanates in which R is isopropyl are preferably used.
- Methyl, phenyl, cyclopropyl or p-fluorophenyltriisopropyl titanates are very preferably used.
- carboxamides of the general formula (II) can be reacted with good yields in the process described here, in which R 1 , R 2 and R 3 can independently assume the following meanings:
- Methyl- or ethyl-substituted cycloalkyl groups or mono- or polyunsaturated cycloalkyl groups such as cyclopentenyl or cyclopentadienyl or branched or unbranched alkenyl with 2 to 10 C atoms, such as allyl, vinyl, isopropenyl, propenyl or branched or unbranched alkynyl with 2 to 10 C.
- Atoms such as ethynyl, propynyl or
- Aralkenyl or aralkynyl where in each case the aryl, alkenyl and alkynyl group can assume the given meanings, such as in phenylethynyl.
- Form ring with 3-8 C atoms which contains nitrogen, as well as other heteroatoms, such as -S-, -O- or -NR 6 -. are particularly preferred here
- R and R or R and R form a cyclic ring which contains an oxygen atom as a further heteroatom.
- R 4 and R 5 preferably represent an alkyl radical having 1 to 10 carbon atoms, such as methyl, i-propyl, i- or tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and their suitable isomers, or cycloalkyl with 3-8 C atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or corresponding methyl- or ethyl-substituted cycloalkyl groups or mono- or polyunsaturated cycloalkyl groups, such as cyclopentenyl or cyclopentadienyl or branched or unbranched alkenyl with 2 to 10 carbon atoms, such as allyl, isopropenyl, propenyl or branched or unbranched al
- aryl radicals with 6 to 20 C atoms optionally unsubstituted or mono- or polysubstituted, such as phenyl, naphthyl, anthryl, phenanthryl, monosubstituted or polysubstituted by substituents selected from the group NO 2 , F, Cl, Br, NH 2 , NHA, NA 2 , OH and OA, where A can have the meanings given above, can be single, multiple or fully halogenated, preferably fluorinated, or
- aralkyl radicals with 7 to 20 carbon atoms such as benzyl
- substituents selected from the group NO 2 , F, Cl, Br, NH 2 , NHA, NA 2 , OH and OA, where A is the can have meanings given above, can be single, multiple or fully halogenated, preferably fluorinated
- Alkynyl group can take the given meanings, e.g. in phenylethynyl.
- the radical Z in the general formula (III) preferably represents a MgX radical with X for Cl or Br or the Z radical for lithium.
- Grignard compounds such as: methyl magnesium bromide, i-propyl magnesium bromide, i- or tert-butyl magnesium bromide, cyclopropyl magnesium bromide, cyclohexyl magnesium chloride, allyl magnesium bromide, cyclopentyl magnesium bromide, cyclopentyl magnesium are particularly preferred Phenylmagnesium chloride, p-fluorophenylmagnesium bromide used for the implementation.
- the organotitanate preferably organotitanium triisopropylate
- Suitable solvents are e.g. aliphatic or aromatic hydrocarbons or ethers.
- Solvents selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether are preferably used, which are dried before the reaction by methods known to the person skilled in the art. Drying can be done using magnesium sulfate, calcium chloride, sodium, potassium hydroxide or other methods.
- a preferred embodiment of the process according to the invention is that the organotitanium triisopropylate used in an amount of 0.7 to 1.3, preferably 0.9 to 1.1 equivalents, based on one mole of the amide used as starting material, is initially introduced in the form of a solution , which is set to a temperature of 10 to 30 ° C, preferably to 15-25 ° C, particularly preferably to a temperature of about 20 ° C. Under an inert gas atmosphere (nitrogen or argon), the starting material is slowly added dropwise either as such in liquid form or dissolved in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether with stirring.
- a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether with stirring.
- the reaction mixture is stirred for a short time, ie for a few minutes, at a constant temperature.
- To the reaction mixture thus obtained is then slowly added as much nucleophilic reagent of the general formula (III), in particular Grignard reagent, that a substitution of the geminal carbonyl-C atom by two identical or different substituents, ie a symmetrical or asymmetrical substitution of the geminal carbonyl-C -Atoms can be done.
- the nucleophilic reagent according to the invention prepared according to methods well known to those skilled in the art, should be added so slowly that the temperature of the reaction mixture does not exceed 50.degree.
- the nucleophilic reagent ie the Grignard reagent or the lithium compound
- the nucleophilic reagent used preferably Grignard reagent
- the nucleophilic reagent used is added in an amount of 0.7 to 1.3 moles per mole of reactant reactant.
- the Grignard reagent is preferably added in an amount of 0.9 to 1.1 mol based on 1 mol of educt and in the same amount as the organotitanate.
- the reaction mixture is stirred at constant temperature for some time until the reaction is complete.
- reaction mixture can be worked up in a manner known to the person skilled in the art.
- the products can be used as salts with the help of hydrochloric acid solutions such.
- hydrochloric acid solutions such.
- a suitable amount of saturated ammonium chloride solution and water can be added and stirring is continued intensively for several hours (1-3 hours).
- the resulting precipitate is separated off and washed with a little ether, preferably diethyl ether.
- the filtrate is made basic (pH> 10) by adding a suitable alkali, such as a NaOH, KOH, sodium or potassium carbonate solution, preferably sodium hydroxide solution.
- a suitable alkali such as a NaOH, KOH, sodium or potassium carbonate solution, preferably sodium hydroxide solution.
- the phases that form are then separated and the aqueous phase is extracted several times (e.g. three times with 30 ml each in the above special case) with diethyl ether.
- the combined organic phases are washed with (e.g. 15 ml) saturated sodium chloride solution and can be dried over potassium carbonate, magnesium sulfate or sodium sulfate and filtered.
- the products can be purified in various ways by methods known to those skilled in the art, e.g. in the following way:
- the organic phase is extracted several times with a 0.5 M acid solution, preferably an aqueous hydrochloric acid solution.
- the extract obtained is adjusted to pH> 10 using lyes, preferably 2 M sodium hydroxide solution, and extracted at least once, preferably several times, with diethyl ether.
- the organic phases obtained which contain the reaction product can optionally be dried over potassium carbonate, magnesium sulfate or sodium sulfate and freed from the organic solvent under vacuum.
- the Grignard reagents can also be replaced by the corresponding lithium compounds.
- the corresponding lithium compounds can be prepared by the methods generally known to the person skilled in the art and can be reacted according to the invention in the same manner as described above. 5
- the compounds of general formula (I) prepared according to the invention can, for. B. as intermediates for the production of sulfur- or selenium-containing amines for the chiral catalysis of diethylzinc syntheses (literature: Werth, Thomas; Tetrahedron Lett. 36; 1995, 7849-7852, Werth, Thomas et all. Helv. Chim. Acta 79, 1996, 1957-1966) can be used. 0
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99931109A EP1087931A1 (de) | 1998-06-18 | 1999-06-18 | Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien |
KR1020007014423A KR20010053016A (ko) | 1998-06-18 | 1999-06-18 | 유기티타네이트 및 그리냐르 시약을 사용하는 카복실산아미드의 대칭 및 비대칭 이치환 방법 |
US09/719,971 US6479661B1 (en) | 1998-06-18 | 1999-06-18 | Method for symmetrically and asymmetrically disubstituting carboxylic acid amides with organotitanates and grignard reagents |
JP2000554688A JP2002518364A (ja) | 1998-06-18 | 1999-06-18 | 有機チタネートおよびグリニャール試薬を用いてカルボキサミドを対称および非対称二置換する方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19827167 | 1998-06-18 | ||
DE19827167.0 | 1998-06-18 | ||
DE19844194.0 | 1998-09-26 | ||
DE19844194A DE19844194A1 (de) | 1998-06-18 | 1998-09-26 | Verfahren zur symmetrischen oder unsymmetrischen Disubstitution von Carbonsäureamiden mit Organotitanaten und Grignardreagenzien |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999065861A1 true WO1999065861A1 (de) | 1999-12-23 |
Family
ID=26046885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/004253 WO1999065861A1 (de) | 1998-06-18 | 1999-06-18 | Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien |
Country Status (4)
Country | Link |
---|---|
US (1) | US6479661B1 (de) |
EP (1) | EP1087931A1 (de) |
JP (1) | JP2002518364A (de) |
WO (1) | WO1999065861A1 (de) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044160A2 (de) * | 1999-12-14 | 2001-06-21 | Merck Patent Gmbh | Verfahren zur herstellung kombinatorischer aminbibliotheken |
US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
US9174971B2 (en) | 2009-10-14 | 2015-11-03 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of SGLT2 |
US10544135B2 (en) | 2011-04-13 | 2020-01-28 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of SGLT2 |
US10617668B2 (en) | 2010-05-11 | 2020-04-14 | Janssen Pharmaceutica Nv | Pharmaceutical formulations |
US11576894B2 (en) | 2009-07-08 | 2023-02-14 | Janssen Pharmaceutica Nv | Combination therapy for the treatment of diabetes |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005307772B2 (en) * | 2004-11-16 | 2010-06-10 | Limerick Biopharma, Inc. | Methods and compositions for treating pain |
US20070087977A1 (en) * | 2004-11-16 | 2007-04-19 | Wendye Robbins | Methods and compositions for treating pain |
-
1999
- 1999-06-18 US US09/719,971 patent/US6479661B1/en not_active Expired - Fee Related
- 1999-06-18 EP EP99931109A patent/EP1087931A1/de not_active Ceased
- 1999-06-18 WO PCT/EP1999/004253 patent/WO1999065861A1/de not_active Application Discontinuation
- 1999-06-18 JP JP2000554688A patent/JP2002518364A/ja active Pending
Non-Patent Citations (8)
Title |
---|
"BEILSTEINS HANDBUCH DER ORGANISCHEN CHEMIE, vierte Auflage, drittes und viertes Ergänzungswerk, Bd 20, erster Teil, S. 316", 1977, SPRINGER-VERLAG, BERLIN . HEIDELBERG . NEW YORK, XP002117681 * |
"HOUBEN-WEYL, METHODEN DER ORGANISCHEN CHEMIE, vol. XI/1, S. 820-823", 1957, GEORG THIEME VERLAG, STUTTGART, DE, XP002117680 * |
JERRY MARCH: "Advanced organic chemistry", 1985, JOHN WILEY, NEW YORK . CHISCHESTER . BRISBANE . TORONTO . SINGAPORE, XP002117736 * |
KUFFNER F. ET AL.: "Über hochverzweigte aliphatische Verbindungen", MONATSHEFTE FÜR CHEMIE, vol. 93, 1962, pages 496 - 475, XP002117676 * |
MANFRED T. REETZ ET AL.: "Chemoselective addition of organotitanium reagents to carbonyl compounds", CHEMISCHE BERICHTE., vol. 118, no. 4, 1985, VERLAG CHEMIE GMBH. WEINHEIM., DE, pages 1421 - 1440, XP002117770, ISSN: 0009-2940 * |
VLADIMIR CHAPLINSKI ET AL.: "A new versatile reagent for the synthesis of cyclopropylamines...", SYNLETT., 1997, THIEME VERLAG, STUTTGART., DE, pages 111 - 114, XP002117679, ISSN: 0936-5214 * |
VLADIMIR CHAPLINSKI ET AL.: "Eine nützliche Synthese von Cyclopropylaminen aus Carbonsäurediakylamiden", ANGEWANDTE CHEMIE., vol. 108, no. 4, 1996, VCH VERLAGSGESELLSCHAFT, WEINHEIM., DE, pages 491 - 492, XP002117735, ISSN: 0044-8249 * |
YUYING C. HWANG ET AL.: "A synthesis of &-substituted amines", JOURNAL OF ORGANIC CHEMISTRY., vol. 50, no. 20, 1985, EASTON US, pages 3885 - 3890, XP002117673 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044160A2 (de) * | 1999-12-14 | 2001-06-21 | Merck Patent Gmbh | Verfahren zur herstellung kombinatorischer aminbibliotheken |
WO2001044160A3 (de) * | 1999-12-14 | 2002-03-07 | Merck Patent Gmbh | Verfahren zur herstellung kombinatorischer aminbibliotheken |
US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
US11576894B2 (en) | 2009-07-08 | 2023-02-14 | Janssen Pharmaceutica Nv | Combination therapy for the treatment of diabetes |
US9174971B2 (en) | 2009-10-14 | 2015-11-03 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of SGLT2 |
US10617668B2 (en) | 2010-05-11 | 2020-04-14 | Janssen Pharmaceutica Nv | Pharmaceutical formulations |
US10544135B2 (en) | 2011-04-13 | 2020-01-28 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of SGLT2 |
Also Published As
Publication number | Publication date |
---|---|
EP1087931A1 (de) | 2001-04-04 |
US6479661B1 (en) | 2002-11-12 |
JP2002518364A (ja) | 2002-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1087928A1 (de) | Katalytisch titan(iv)-oxid vermittelte geminale symmetrische dialkylierung von carbonsäureamiden | |
DE2753124C2 (de) | ||
EP3663284A1 (de) | Verbessertes verfahren zur herstellung von triacetonamin | |
WO1999065861A1 (de) | Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien | |
DE3514450A1 (de) | Verfahren zur herstellung von imidaten sowie neue arylsubstituierte imidate | |
DE3531067A1 (de) | Verfahren zur herstellung von 3-aminoacrylsaeureestern | |
CH631969A5 (de) | Verfahren zur herstellung von aminen. | |
WO1999065862A1 (de) | Verfahren zur katalytischen, symmetrischen disubstitution von carbonsäureamiden mit grignard-reagenzien | |
DE2602846C2 (de) | Verfahren zur Herstellung von 2-(2-Thienyl)äthylaminen | |
EP1087927A1 (de) | Verfahren zur katalytischen, unsymmetrischen disubstitution von carbonsäureamiden mit zwei unterschiedlichen grignard-reagenzien | |
EP0790251B1 (de) | Herstellung und Verwendung von (3-Alkoxyphenyl)magnesiumchloriden | |
EP1087929A1 (de) | Verfahren zur herstellung von kombinatorischen aminbibliotheken | |
EP1087932A1 (de) | Katalytisch titan(iv)-oxid vermittelte geminale unsymmetrische dialkylierung von carbonsäureamiden | |
EP1087930A1 (de) | Verfahren zur katalytischen disubstitution von carbonsäureamiden mit wenigstens einem grignard-reagenz | |
DE2943192A1 (de) | Verfahren zur herstellung von indolin-derivaten | |
DE2102809A1 (de) | Mehrphasen- Aminierungsverfahren | |
DE3121766A1 (de) | Verfahren zur herstellung basisch substituierter phenylacetonitrile | |
DE2005515A1 (de) | P 08.02.69 Niederlande 6902028 Verfahren zur Herstellung von gamma-Cyanobutyraläiminen | |
DE19632643C1 (de) | Katalysierte Kopplung von Arylmagnesiumhalogeniden und Bromarylcarbonsäureverbindungen zur Herstellung von Biphenylcarbonsäuren | |
DE2065698A1 (de) | Verfahren zur herstellung von 2isopropyl-6-methyl-4(3h)-pyrimidon | |
AT325600B (de) | Verfahren zur herstellung von arylalkylpyrrylaminoäthanolen und ihren salzen | |
DE2433176A1 (de) | 2-halopyrimidinderivate und verfahren zu ihrer herstellung | |
EP1483226B1 (de) | Verbessertes verfahren zur herstellung von 4-(6-bromhexyloxy)-butylbenzol | |
DE2456600A1 (de) | Verfahren zur herstellung von poly-n-alkyliminoalanen | |
DE1225184B (de) | Verfahren zur Herstellung von Bis-tetrahydroisochinolinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999931109 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007014423 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09719971 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999931109 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007014423 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020007014423 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: 1999931109 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999931109 Country of ref document: EP |